alexa
Reach Us +44-1904-929220
Personal Health Monitoring And Preventative Medicine With Integrative Personal Omics Profiling | 3572
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Personal health monitoring and preventative medicine with integrative personal Omics profiling

3rd International Conference on Biomarkers & Clinical Research

Rui Chen

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.009

Abstract
With the advent of new high-throughput technologies it is now possible to monitor profiles of thousands of molecules in a longitudinal manner that may help reshape and redefine personalized medicine. Comprehensive personal healthy monitoring is expected to benefit from combining genomic information with regular examination of physiological states by multiple high-throughput methods. To prove this principle, we performed an integrative Personal Omics Profile (iPOP) analysis from a single individual over a 14-month period, combining genomic, transcriptomic, proteomic, metabolomic, and autoantibodyomic information collected from over 20 time points. Our iPOP analysis unveiled extensive, dynamic molecular changes across various physiological stages. Medical risks were also evaluated using genomic information, including Type 2 Diabetes (T2D) as a high risk disease, the onset of which was observed during the course of our study and is reflected in our iPOP data. Our study demonstrates that personal health monitoring with longitudinal iPOP could relate genomic information and global functional omics activity to physiological and medical interpretation, and eventually benefit personalized medicine.
Biography
Dr. Rui Chen completed his Ph.D. at Yale University in 2008 with the John Spangler Nicholas Prize, a prestigious award for most outstanding Ph.D. candidates in Biology, and is currently a Postdoctoral Scholar training with Dr. Michael Snyder at Yale University and Stanford University. Dr. Chen has extensive experience in disease-related research and disease-orientated technology development, and is currently focusing on personalized healthy monitoring and preventative medicine with next-generation, high-throughput technologies.
Relevant Topics
Top